DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
DexCom
DXCM
Hutchmed (China)
HCM
New Fortress Energy
NFE
Enerpac Tool
EPAC
US Stock MarketDetailed Quotes
ELVN Enliven Therapeutics
- 21.680
- +0.180+0.84%
Close Feb 14 16:00 ET
- 21.680
- 0.0000.00%
Post 16:01 ET
1.06BMarket Cap-12.02P/E (TTM)
22.375High21.170Low387.41KVolume21.640Open21.500Pre Close8.37MTurnover1.46%Turnover RatioLossP/E (Static)48.86MShares30.03052wk High3.67P/B573.86MFloat Cap10.90052wk Low--Dividend TTM26.47MShs Float250.840Historical High--Div YieldTTM5.61%Amplitude3.896Historical Low21.613Avg Price1Lot Size
Enliven Therapeutics News
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Enliven Therapeutics | SCHEDULE 13G/A: Others
Enliven Therapeutics | SCHEDULE 13G/A: Others
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Phillips Andrew John
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kunkel Lori Anne
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Heyman Richard A.
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gupta Rishi
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ballal Rahul D.
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bauer Jake
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Derynck Mika K
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Patel Anish
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kintz Samuel
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lyssikatos Joseph P
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hohl Benjamin
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Collins Helen Louise
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hohl Benjamin
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hohl Benjamin
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144